Literature DB >> 1486300

Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis.

P Emery1, M Salmon, H Bradley, P Wordsworth, E Tunn, P A Bacon, R Waring.   

Abstract

OBJECTIVE: To determine whether genetic factors associated with established rheumatoid arthritis could, in combination with rheumatoid factor, predict the development of radiological erosions in patients with early symmetrical (rheumatoid-like) arthritis.
DESIGN: Prospective study.
SETTING: Teaching hospital, early arthritis clinic.
SUBJECTS: Forty nine patients with symmetrical polyarthritis attending the early arthritis clinic. MAIN OUTCOME MEASURES: Conserved sequence of DR beta third allelic hypervariable region, sulphoxidation capacity, rheumatoid factor, and development of radiologically determined bone erosions.
RESULTS: None of the 49 patients had radiological erosions at presentation but 25 developed these by four years. Patients with the conserved class II major histocompatibility complex (third allelic hypervariable of DR beta 1) genes associated with rheumatoid arthritis had a relative risk for the development of erosions of 1.9 (95% confidence interval 0.8 to 4.5). For poor sulphoxidation the risk was 2.5 (1.1 to 5.6) and for the presence of rheumatoid factor 1.8 (0.9 to 3.7). Of the 33 patients who had two or three of these risk factors, 24 developed erosions, with a relative risk of 11.6 (1.7 to 78.5) compared with only one of the 16 individuals with no or one risk factor.
CONCLUSIONS: This preliminary study shows that by using these stable markers it is possible to make clinically useful predictions of outcome in patients with early symmetrical inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486300      PMCID: PMC1883968          DOI: 10.1136/bmj.305.6866.1387

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment.

Authors:  P Emery; H Bradley; A Gough; V Arthur; R Jubb; R Waring
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 2.  Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.

Authors:  D M van der Heijde; P L van Riel; M H van Rijswijk; L B van de Putte
Journal:  Semin Arthritis Rheum       Date:  1988-05       Impact factor: 5.532

3.  Molecular diversity of HLA-DR4 haplotypes.

Authors:  P K Gregersen; M Shen; Q L Song; P Merryman; S Degar; T Seki; J Maccari; D Goldberg; H Murphy; J Schwenzer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 4.  The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis.

Authors:  R J Winchester; P K Gregersen
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

6.  Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive associations with HLA-DR4, DR1 and DRw10.

Authors:  B P Wordsworth; J Stedeford; W M Rosenberg; J I Bell
Journal:  Br J Rheumatol       Date:  1991-06

7.  Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis.

Authors:  R F Willkens; G T Nepom; C R Marks; J W Nettles; B S Nepom
Journal:  Arthritis Rheum       Date:  1991-01

8.  D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.

Authors:  P Emery; G S Panayi; G Huston; K I Welsh; S C Mitchell; R R Shah; J R Idle; R L Smith; R H Waring
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

9.  HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.

Authors:  B P Wordsworth; J S Lanchbury; L I Sakkas; K I Welsh; G S Panayi; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

  9 in total
  14 in total

1.  Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis.

Authors:  J van Aken; L R Lard; S le Cessie; J M W Hazes; F C Breedveld; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

Review 2.  Should patients with recent onset rheumatoid arthritis be offered genetic screening?

Authors:  D P Symmons; W E Ollier; P Brennan; A J Silman
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

3.  Algorithm to predict radiological erosions in early rheumatoid arthritis. Messages from paper are incorrect.

Authors:  P Emery; A Gough; J Devlin; M Green
Journal:  BMJ       Date:  1996-11-30

4.  Economic evaluation in rheumatology: a necessity for clinical studies.

Authors:  B Griffiths; P Emery; R Akehurst
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

5.  Medical management of rheumatoid arthritis.

Authors:  P Emery; A Gough; M Salmon; J Devlin
Journal:  BMJ       Date:  1993-10-09

6.  Early rheumatoid arthritis: time to aim for remission?

Authors:  P Emery; M Salmon
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

7.  Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide.

Authors:  Iori Ueki; Heather B Roman; Alessandro Valli; Krista Fieselmann; Jimmy Lam; Rachel Peters; Lawrence L Hirschberger; Martha H Stipanuk
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-06-21       Impact factor: 4.310

8.  HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments.

Authors:  J R O'Dell; B S Nepom; C Haire; V H Gersuk; L Gaur; G F Moore; W Drymalski; W Palmer; P J Eckhoff; L W Klassen; S Wees; G Thiele; G T Nepom
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

9.  Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA.

Authors:  Y Toda; Y Minamikawa; S Akagi; H Sugano; Y Mori; H Nishimura; S Arita; Y Sugino; R Ogawa
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

Review 10.  Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels.

Authors:  M H Stipanuk; I Ueki; J E Dominy; C R Simmons; L L Hirschberger
Journal:  Amino Acids       Date:  2008-11-15       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.